DynaCT引导下125I粒子治疗胸腺瘤胸膜转移16例临床分析  

Effect of 125 I radioactive seed in treatment of thymoma pleural metastases under Dyna CT：a retrospective analysis

作　　者：邓极燃 吴正阳[2] 焦德超[2] 

机构地区：[1]自贡市第一人民医院介入科,四川省自贡643000 [2]郑州大学第一附属医院介入科

出　　处：《中国基层医药》2015年第20期3104-3106,共3页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的：探讨放射性125 I 粒子植入治疗侵袭性胸腺瘤切除术后胸膜转移的可行性和临床疗效。方法回顾性分析16例胸腺瘤患者的临床资料，均行手术切除，病理证实为侵袭性胸腺瘤，术后发生胸膜不同程度转移，均采用放射性粒子植入。结果16例患者手术顺利，无严重并发症。随访12个月，随访期末13例肿瘤完全或部分缓解，2例进展，1例失访。结论DynaCT 引导下行放射性粒子植入治疗侵袭性胸腺瘤胸膜转移疗效确切，安全，为治疗胸膜转移瘤提供了一个新的、可行的治疗手段。Objective To evaluate the feasibility and efficacy of 125 I radioactive seed implantation in treat-ment of aggressive thymoma pleural metastases after surgical resection.Methods The clinical data of 16 patients with thymoma confirmed underwent surgery were retrospectively analyzed.All post -operative pleural metastasis were trea-ted by radioactive particle planting.Results No patients occurred serious complications.15 patients survived at the end of 12 months following -up,13 patients with complete or partial relieved,2 patients progressed and 1 patient lost to following -up.Conclusion DynaCT -guided 125 I radioactive seed implantation is effective and safe for treating aggressive thymoma pleural carcinomatosis,it offers a new and feasible treatment.

关 键 词：胸膜瘤 肿瘤转移 放射性同位素 

分 类 号：R736.3[医药卫生—肿瘤]